Obermatt
See Similar Stocks →

Flags

Financial distress

Ingevity

NYQ:NGVT · US45688C1071
ChemicalsMedium

360

18
EV / EBIT52
Price / Owner Earnings87
Owner Earnings Yield1
Dividend Yield1
Price/Sales33
EV / Gross Profit30
Price/Book3
Return on Capital82
Cash Return on Capital8
Return on Equity1
EBIT Margin91
Gross Profitability79
Accruals100
Owner Earnings Margin8
Sales growth1
Profit Growth42
Long-Term EPS Growth74
Reinvestment23
Price momentum85
Debt load3
Refinancing37
Debt Payback1
Liquidity53
Analyst ratings60
Opinion Changes50
Price Target Upside73
Market mood35
Value Creation6/20not creating value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Ingevity doesn't consistently earn more than its cost of capital, so it isn't yet creating shareholder value.

Profile

CountryUSA
IndustryChemicals
SizeMedium
TypePublic Company
ExchangeNYSE
Founded2015
Employees786
Websiteingevity.com
ISINUS45688C1071
Last UpdateApr 2, 2026
Index & Theme
Bio-based and Renewable MaterialsDisposal and RecyclingWater PurificationCleanTechPollution ControlNutraceuticalChemical

Description

Ingevity Corporation (Ingevity) provides products and technologies that purify, protect, and enhance the world. Through a diverse team of talented and experienced people, the company develops, manufactures, and brings to market solutions that are la…

Analysis

Middle-of-the-road

Ingevity Corporation sits in the middle of our grid: average quality, average price, no obvious signal in either direction.

Valuation data is not available for this company.

Growth is moderate; the safety picture is fragile. The company scores 6/20 on our value-creation score: not creating value.

No flags apply to this company at this time: accounts, balance sheet, and cash quality all pass. A clean bill of health is meaningful, not just the absence of a warning. This analysis describes numbers; it is not investment advice.

360° rank · history

1007550250
10
2023202420252026

All-time high

28

Mar 2026

All-time low

3

Jan 2023

Average rank

12

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
33
69
57
34
Price/Earnings
54
86
65
61
Price/Book
3
9
42
42
Dividend Yield
1
1
1
1
Value (overall)
9
47
35
19

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Ingevity with its peers
AdvanSix
NYQ:ASIX
19
CountryUSA
IndustryChemicals
SizeMedium
Full Stock Analysis →
Ascent Industries
NMQ:ACNT
35
CountryUSA
IndustryChemicals
SizeSmall
Full Stock Analysis →
Trinseo
NYQ:TSE
5
CountryUSA
IndustryChemicals
SizeMedium
Full Stock Analysis →
Innospec
NSQ:IOSP
84
CountryUSA
IndustryChemicals
SizeMedium
Full Stock Analysis →
ASP Isotopes
NAQ:ASPI
22
CountryUSA
IndustryChemicals
SizeSmall
Full Stock Analysis →
Stepan
NYQ:SCL
21
CountryUSA
IndustryChemicals
SizeMedium
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →